Stay updated with breaking news from Conjoint Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CAR T-cell therapy market for acute lymphoblastic leukemia is poised for substantial growth, driven by the anticipated launch of therapies such as OBECABTAGENE AUTOLEUCEL (OBE-CEL), UCART22
According to DelveInsight’s analysis, the growth of the gene therapies market in ophthalmology is expected to be mainly driven by the increasing prevalence of eye disease, rise in awareness and access to treatment, increased adoption of enhanced genetic testing and robust pipeline activity for eye disease in the 7MM. LAS VEGAS, April 4, 2024 /PRNewswire/ […]
/PRNewswire/ -- DelveInsight's Gene Therapies in Ophthalmology Market Insights report includes a comprehensive understanding of current treatment practices,...
/PRNewswire/ -- DelveInsight's Diabetic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, diabetic...
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ResearchAndMarkets.com's offering.This report comprises of detailed understanding of the Nonalcoholic Steatohepatitis (NASH), historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia)